×
About 20,900 results

ALLMedicine™ Pulmonary Embolism Center

Research & Reviews  6,650 results

Xarelto for Real Life Anticoagulation in Pulmonary Embolism (PE) in China
https://clinicaltrials.gov/ct2/show/NCT03410706

Dec 3rd, 2021 - EINSTEIN PE study demonstrated that rivaroxaban is at least as effective as the current standard therapy with 51% relative risk reduction of major bleeding (1.1% vs. 2.2%, HR 0.49, 95% CI, 0.31-0.79), in the treatment and secondary prevention of P...

Predictive value of D-dimer and analysis of risk factors in pregnant women with suspect...
https://doi.org/10.1186/s12890-021-01757-3
BMC Pulmonary Medicine; Zhang L, Chen Y et. al.

Dec 3rd, 2021 - Acute pulmonary embolism (PE) is one of the leading causes of maternal mortality, and cesarean section is an established independent risk factor for PE. The diagnostic utility of D-dimer for PE in non-pregnant women has been well-established, but ...

Predictive scores for the diagnosis of Pulmonary Embolism in COVID-19: A systematic rev...
https://doi.org/10.1016/j.ijid.2021.11.038
International Journal of Infectious Diseases : IJID : Off... Rindi LV, Moghazi SA et. al.

Dec 2nd, 2021 - During the COVID-19 pandemic, several studies described an increased chance of developing pulmonary embolism (PE). Several scores have been used to predict the occurrence of PE. In this systematic review, we aim at summarizing the literature on pr...

see more →

Guidelines  23 results

Appropriate Use of Point-of-Care Ultrasonography in Patients With Acute Dyspnea in Emer...
https://doi.org/10.7326/M20-7844
Annals of Internal Medicine; Qaseem A, Etxeandia-Ikobaltzeta I et. al.

Apr 27th, 2021 - The American College of Physicians (ACP) developed this guideline to provide clinical recommendations on the appropriate use of point-of-care ultrasonography (POCUS) in patients with acute dyspnea in emergency department (ED) or inpatient settings...

Emerging challenges in the evaluation of fever in cancer patients at risk of febrile ne...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682766
Supportive Care in Cancer : Official Journal of the Multi... Cooksley T, Font C et. al.

Nov 25th, 2020 - Patients with cancer are at higher risk of more severe COVID-19 infection and have more associated complications. The position paper describes the management of cancer patients, especially those receiving anticancer treatment, during the COVID-19 ...

American Society of Hematology 2020 guidelines for management of venous thromboembolism...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556153
Blood Advances; Ortel TL, Neumann I et. al.

Oct 3rd, 2020 - Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism (PE), occurs in ∼1 to 2 individuals per 1000 each year, corresponding to ∼300 000 to 600 000 events in the United States annually. These evidence-based ...

Management of Acute Pulmonary Embolism.
https://doi.org/10.1001/jama.2020.3905
JAMA Paul JD, Cifu AS

Aug 12th, 2020 - Management of Acute Pulmonary Embolism.|2020|Paul JD,Cifu AS,|administration & dosage,administration & dosage,standards,diagnosis,mortality,therapy,standards,standards,standards,adverse effects,methods,mortality,standards,complications,therapy,

ACR Appropriateness Criteria® Radiologic Management of Iliofemoral Venous Thrombosis.
https://doi.org/10.1016/j.jacr.2020.01.035
Journal of the American College of Radiology : JACR; , Farsad K et. al.

May 7th, 2020 - Iliofemoral venous thrombosis carries a high risk for pulmonary embolism, recurrent deep vein thrombosis, and post-thrombotic syndrome complicating 30% to 71% of those affected. The clinical scenarios in which iliofemoral venous thrombosis is mana...

see more →

Drugs  248 results see all →

Clinicaltrials.gov  280 results

Xarelto for Real Life Anticoagulation in Pulmonary Embolism (PE) in China
https://clinicaltrials.gov/ct2/show/NCT03410706

Dec 3rd, 2021 - EINSTEIN PE study demonstrated that rivaroxaban is at least as effective as the current standard therapy with 51% relative risk reduction of major bleeding (1.1% vs. 2.2%, HR 0.49, 95% CI, 0.31-0.79), in the treatment and secondary prevention of P...

Pulmonary Embolism International THrOmbolysis Study-3
https://clinicaltrials.gov/ct2/show/NCT04430569

Nov 22nd, 2021 - In patients with intermediate-risk pulmonary embolism, full-dose thrombolytic treatment was associated with a reduction in the combined risk of hemodynamic instability or death but was also associated with an increased risk of major and intracrani...

US Pivotal Clinical Study of the Adient Absorbable Filter for the Prevention of Pulmonary Embolism
https://clinicaltrials.gov/ct2/show/NCT05127915

Nov 19th, 2021 - The objective of the study is to evaluate the safety and efficacy of the Adient absorbable filter for the prevention of pulmonary embolism (PE: blood clot in the lungs). PE claims the lives of over 100,000 Americans each year, more than breast can...

Prevalence and Severity of Venous Thromboembolism in a General Population During the COVID-19 Pandemic
https://clinicaltrials.gov/ct2/show/NCT04400877

Nov 18th, 2021 - In the current SARS-COV-2 pandemic there is a concern about an increased risk of venous thromboembolism (VTE) concurrent with the infection, including both pulmonary embolism (PE) and deep venous thrombosis (DVT) (Klok et al. 2020; Cui et al. 2020...

Effects of Buteyko Breathing Technique Versus Incentive Spirometer on Breath Holding Time, Cardiopulmonary Endurance and Quality of Life in Patients With Post Lung Tumor Resection
https://clinicaltrials.gov/ct2/show/NCT05118347

Nov 12th, 2021 - The pulmonary complications are the major cause of morbidity and mortality following Lung surgeries. The Buteyko breathing technique is used for reversing the health condition such as poor breathing, mouth breathing and over breathing. Incentive s...

see more →

News  1,148 results

Neoadjuvant Nivolumab Plus Chemo Significantly Improves EFS in Resectable NSCLC
https://www.onclive.com/view/neoadjuvant-nivolumab-plus-chemo-significantly-improves-efs-in-resectable-nscl

Nov 22nd, 2021 - The addition of nivolumab (Opdivo) to chemotherapy resulted in a statistically significant and clinically meaningful improvement in event-free survival (EFS) vs chemotherapy alone, when administered prior to surgery in patients with resectable sta...

Risk for VTE in RA may be higher with MTX vs. hydroxychloroquine
https://www.mdedge.com/rheumatology/article/248176/rheumatoid-arthritis/risk-vte-ra-may-be-higher-mtx-vs-hydroxychloroquine
Caleb Rans, PharmD

Nov 2nd, 2021 - Patients with rheumatoid arthritis who are treated with methotrexate (MTX) are more than twice as likely to develop venous thromboembolism (VTE) when compared with patients who use hydroxychloroquine, according to data from a propensity score–matc.

Respiratory, Cardiac, and Neurological Red Flags for Long COVID
https://www.medscape.com/viewarticle/961034

Oct 18th, 2021 - Editor's note, 18 October 2021: This article was updated to correct the title 'occupational therapists'. Watch for the big three red flags – cardiac (ischaemia, tachyarrhythmia, myocarditis and pericarditis), neurological (TIA and stroke) and resp...

D-dimer Unreliable for Ruling Out Pulmonary Embolism in COVID-19
https://www.medscape.com/viewarticle/960826

Oct 13th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The plasma D-dimer assay has been used, along with clinical prediction scores, to rule out pulmonary embolism (PE) in critically ill patients for ...

Balancing the Risk and Benefit of Anticoagulation in Patients on BTKi
https://www.onclive.com/view/balancing-the-risk-and-benefit-of-anticoagulation-in-patients-on-btki

Oct 7th, 2021 - Farrukh Awan, MD: We’ll keep talking about specific things. I’ll tell you a few specific issues that I deal with. I’m sure a lot of people in the audience might have to deal with these issues. I’ve had problems, and I’ve had discussions, arguments...

see more →

Patient Education  11 results see all →